346 related articles for article (PubMed ID: 20665017)
1. Marine bacterial isolates inhibit biofilm formation and disrupt mature biofilms of Pseudomonas aeruginosa PAO1.
Nithya C; Begum MF; Pandian SK
Appl Microbiol Biotechnol; 2010 Sep; 88(1):341-58. PubMed ID: 20665017
[TBL] [Abstract][Full Text] [Related]
2. A novel compound from the marine bacterium Bacillus pumilus S6-15 inhibits biofilm formation in gram-positive and gram-negative species.
Nithya C; Devi MG; Karutha Pandian S
Biofouling; 2011 May; 27(5):519-28. PubMed ID: 21614700
[TBL] [Abstract][Full Text] [Related]
3. The in vitro antibiofilm activity of selected marine bacterial culture supernatants against Vibrio spp.
Nithya C; Pandian SK
Arch Microbiol; 2010 Oct; 192(10):843-54. PubMed ID: 20697692
[TBL] [Abstract][Full Text] [Related]
4. Rhamnolipid mediated disruption of marine Bacillus pumilus biofilms.
Dusane DH; Nancharaiah YV; Zinjarde SS; Venugopalan VP
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):242-8. PubMed ID: 20688490
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures.
Tré-Hardy M; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2008 Apr; 31(4):329-36. PubMed ID: 18280117
[TBL] [Abstract][Full Text] [Related]
6. Antibiofilm activity of coral-associated bacteria against different clinical M serotypes of Streptococcus pyogenes.
Thenmozhi R; Nithyanand P; Rathna J; Pandian SK
FEMS Immunol Med Microbiol; 2009 Dec; 57(3):284-94. PubMed ID: 19845763
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
8. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal.
Harmsen M; Yang L; Pamp SJ; Tolker-Nielsen T
FEMS Immunol Med Microbiol; 2010 Aug; 59(3):253-68. PubMed ID: 20497222
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
[TBL] [Abstract][Full Text] [Related]
10. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and dispersion of Pseudomonas aeruginosa biofilms with reverse amide 2-aminoimidazole oroidin analogues.
Richards JJ; Ballard TE; Melander C
Org Biomol Chem; 2008 Apr; 6(8):1356-63. PubMed ID: 18385842
[TBL] [Abstract][Full Text] [Related]
12. Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes.
Limsuwan S; Voravuthikunchai SP
FEMS Immunol Med Microbiol; 2008 Aug; 53(3):429-36. PubMed ID: 18631184
[TBL] [Abstract][Full Text] [Related]
13. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
14. Influence of biofilm formation in the susceptibility of Pseudomonas aeruginosa from Brazilian patients with cystic fibrosis.
Ferreira AG; Leão RS; Carvalho-Assef AP; Folescu TW; Barth AL; Marques EA
APMIS; 2010 Aug; 118(8):606-12. PubMed ID: 20666742
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibiotic co-administration on young and mature biofilms of cystic fibrosis clinical isolates: the importance of the biofilm model.
Tré-Hardy M; Macé C; El Manssouri N; Vanderbist F; Traore H; Devleeschouwer MJ
Int J Antimicrob Agents; 2009 Jan; 33(1):40-5. PubMed ID: 18801647
[TBL] [Abstract][Full Text] [Related]
16. Persister cells, the biofilm matrix and tolerance to metal cations in biofilm and planktonic Pseudomonas aeruginosa.
Harrison JJ; Turner RJ; Ceri H
Environ Microbiol; 2005 Jul; 7(7):981-94. PubMed ID: 15946294
[TBL] [Abstract][Full Text] [Related]
17. [Foreign body infections--biofilms and quorum sensing].
Høiby N; Johansen HK; Ciofu O; Jensen PØ; Bjarnsholt T; Givskov M
Ugeskr Laeger; 2007 Nov; 169(48):4163-6. PubMed ID: 18211783
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of various antibiotics against biofilm-producing Pseudomonas aeruginosa.
Abdi-Ali A; Mohammadi-Mehr M; Agha Alaei Y
Int J Antimicrob Agents; 2006 Mar; 27(3):196-200. PubMed ID: 16459057
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
